Veterinary Medicine Information website

Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen

Authorised
  • Butorphanol tartrate
Download as PDF

Product identification

Medicine name:
Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen
Active substance:
  • Butorphanol tartrate
Target species:
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol tartrate
    14.58
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
  • Subcutaneous use
    • Cat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 50 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 10 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 59238
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0005/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/07/2024
Updated on: 13/03/2026
Download
English (PDF)
Published on: 12/07/2024
Updated on: 13/03/2026
Download
Danish (, INJEKTIONSVÆSKE, OPLØSNING 10 MG-ML)
Published on: 12/07/2024
Updated on: 13/03/2026
Download

Combined File of all Documents

English (PDF)
Published on: 5/03/2024
Updated on: 13/03/2026
Download

at-puar-atv0005001-mr-buetoemidoer-en.pdf

English (PDF)
Published on: 14/02/2024
Updated on: 13/03/2026
Download

at-puar-atv0005001-mr-buetoemidoer-en.pdf

English (PDF)
Published on: 14/02/2024
Updated on: 13/03/2026
Download